Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy

Journal of the American College of Surgeons

Volumn 221, Issue 6, 2015, Pages 1031-1040.e4

  Bagante, Fabio ^a   Gani, Faiz ^a   Spolverato, Gaya ^a   Xu, Li ^a   Alexandrescu, Sorin ^b   Marques, Hugo P ^c   Lamelas, Jorge ^c   Aldrighetti, Luca ^d   Gamblin, T Clark ^e   Maithel, Shishir K ^f   Pulitano, Carlo ^g   Bauer, Todd W ^h   Shen, Feng ⁱ   Poultsides, George A ^j   Marsh, J Wallis ^k   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b FUNDENI CLINICAL INSTITUTE   (Romania)

^c HOSPITAL CURRY CABRAL   (Portugal)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f EMORY UNIVERSITY   (United States)

^g UNIVERSITY OF SYDNEY   (Australia)

^h UNIVERSITY OF VIRGINIA   (United States)

ⁱ Eastern Hepatobiliary Surgery Hospital   (China)

^j STANFORD UNIVERSITY   (United States)

^k UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; LIVER RESECTION; LIVER SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TUMOR VOLUME; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS;

AGED; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84951791319     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2015.09.012     Document Type: Article

References (26)

1. J. Bridgewater, P.R. Galle, S.A. Khan, and et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma J Hepatol 60 2014 1268 1289
2. N. Amini, A. Ejaz, G. Spolverato, and et al. Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review J Gastrointest Surg 18 2014 2136 2148
3. M. Aljiffry, A. Abdulelah, M. Walsh, and et al. Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature J Am Coll Surg 208 2009 134 147
4. L. Jiang, K.-H. Yang, Q.-L. Guan, and et al. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis J Surg Oncol 107 2013 807 814
5. Y. Shaib, and H.B. El-Serag The epidemiology of cholangiocarcinoma Semin Liver Dis 24 2004 115 125
6. Y.H. Shaib, J.A. Davila, K. McGlynn, and H.B. El-Serag Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40 2004 472 477
7. H. Nathan, T.A. Aloia, J.-N. Vauthey, and et al. A proposed staging system for intrahepatic cholangiocarcinoma Ann Surg Oncol 16 2009 14 22
8. M.C. De Jong, H. Nathan, G.C. Sotiropoulos, and et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment J Clin Oncol 29 2011 3140 3145
9. T. Nakagawa, T. Kamiyama, N. Kurauchi, and et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma World J Surg 29 2005 728 733
10. N. Amini, G. Spolverato, Y. Kim, and et al. Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging/scoring systems J Surg Oncol 111 2015 299 305
11. D.H. Kim, D.W. Choi, S.H. Choi, and et al. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution Surgery 157 2015 666 675
12. Y. Morine, and M. Shimada The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics J Gastroenterol 50 2015 913 927
13. K. Shimada, T. Sano, S. Nara, and et al. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement Surgery 145 2009 411 416
14. E.C. Zabor, M. Gonen, P.B. Chapman, and K.S. Panageas Dynamic prognostication using conditional survival estimates Cancer 119 2013 3589 3592
15. A. Cucchetti, F. Piscaglia, M. Cescon, and et al. Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients Clin Cancer Res 18 2012 4397 4405
16. G. Spolverato, Y. Kim, A. Ejaz, and et al. Conditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 535 patients JAMA Surg 150 2015 538 545
17. D. Hosmer Using Aalen's linear hazards model to investigate time-varying effects in the proportional hazards regression model Stata J 2 2002 331 350 Available at http://www.stata-journal.com/article.html?article=st0024 Accessed August 27, 2015
18. P.C. Austin, P. Grootendorst, and G.M. Anderson A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study Stat Med 26 2007 734 753
19. A. Guglielmi, A. Ruzzenente, T. Campagnaro, and et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma J Gastrointest Surg 17 2013 1917 1928
20. R.M. Dodson, M.J. Weiss, D. Cosgrove, and et al. Intrahepatic cholangiocarcinoma: management options and emerging therapies J Am Coll Surg 217 2013 736 750.e4
21. H.M. Parsons, T.M. Tuttle, K.M. Kuntz, and et al. Association between lymph node evaluation for colon cancer and node positivity over the past 20 years JAMA 306 2011 1089 1097
22. A.L. Gleisner, G. Spolverato, A. Ejaz, and T.M. Pawlik Time-related changes in the prognostic significance of the total number of examined lymph nodes in node-negative pancreatic head cancer J Surg Oncol 110 2014 858 863
23. M.N. Mavros, S.C. Mayo, O. Hyder, and T.M. Pawlik A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma J Am Coll Surg 215 2012 820 830
24. D. Ribero, G. Nuzzo, M. Amisano, and et al. Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma HPB (Oxford) 13 2011 198 205
25. O. Farges, D. Fuks, Y.-P. Le Treut, and et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group Cancer 117 2011 2170 2177
26. A.R. Feinstein, D.M. Sosin, and C.K. Wells The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer N Engl J Med 312 1985 1604 1608